Thursday, May 19, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

People who consume sugar for extended periods have increased risk of autoimmune disease

by Medical Finance
in News
Hospitalization risk high for IBD patients with incomplete COVID-19 vaccinations
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

People who consume sugar and other carbohydrates in excess over a long period of time have an increased risk of developing an autoimmune disease. In affected patients, the immune system attacks the body’s own tissue and the consequences are, for example, chronic inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis, type 1 diabetes and chronic inflammation of the thyroid gland.

New targets for therapy

The underlying molecular mechanisms that promote autoimmune diseases are multilayered and complex. Now, scientists at the Julius Maximilians University of Würzburg (JMU) have succeeded in deciphering new details of these processes.

Their work support the notion that excessive consumption of glucose directly promotes the pathogenic functions of certain cells of the immune system and that, conversely, that a calorie-reduced diet can have a beneficial effect on immune diseases. Based on these findings, they also identified new targets for therapeutic interventions: A specific blockade of glucose-depended metabolic processes in these immune cells can suppress excessive immune reactions.

Dr. Martin Väth is responsible for the study, which has now been published in the journal Cell Metabolism. He is a junior research group leader at the Institute of Systems Immunology – a Max Planck research group under the umbrella of JMU that focusses on the interplay of the immune system with the organism. Collaborators from Amsterdam, Berlin, Freiburg and Leuven were also involved in this study.

Glucose transporter with a side job

Immune cells need large amounts of sugar in the form of glucose to perform their tasks. With the help of specialized transporters at their cell membrane, they can take up glucose from the environment.”


Dr Martin Väth, University of Wurzburg

Together with his team, Väth has showed that a specific glucose transporter – scientifically named GLUT3 – fulfills additional metabolic functions in T cells besides the generating energy from sugar.

In their study, the scientists focused on a group of cells of the immune system that have not been known for very long: T helper cells of type 17, also called Th17 lymphocytes, which play an important role in regulating (auto-) inflammatory processes.

“These Th17 cells express lots of GLUT3 protein on their cell surface,” Väth explains. Once taken up, glucose is readily converted to citric acid in the mitochondria before it is metabolized into acetyl-coenzyme A (acetyl-CoA) in the cytoplasm. Acetyl-CoA is involved in numerous metabolic processes, including the biosynthesis of lipids.

Influence on proinflammatory genes

However, acetyl-CoA fulfills additional functions in inflammatory Th17 cells. Väth and his team showed that this metabolic intermediate can also regulate the activity of various gene segments. Thus, glucose consumption has a direct influence on the activity of proinflammatory genes.

According to the researchers, theses new findings pave the way for the development of targeted therapy of autoimmune diseases. For example, blocking GLUT3-dependent synthesis of acetyl-CoA by the dietary supplement hydroxycitrate, which is used to treat obesity, can mitigate the pathogenic functions of Th17 cells and reduce inflammatory-pathological processes. The so-called “metabolic reprogramming” of T cells opens new possibilities to treat autoimmune diseases without curtailing protective immune cell functions.

Source:

Journal reference:

Hochrein, S. M., et al. (2022) The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming. Cell Metabolism. doi.org/10.1016/j.cmet.2022.02.015

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

‘Lefty’ protein pumps the brakes during initial stages of embryo differentiation

Using ‘off-the-shelf’ engineered stem cell based therapy for treating glioblastomas post-surgery

by Medical Finance
May 19, 2022
0

Glioblastomas (GBMs) are highly aggressive cancerous tumors of the brain and spinal cord. Brain cancers like GBM are challenging to...

New model can localize sounds in the real world

New model can localize sounds in the real world

by Medical Finance
May 19, 2022
0

The human brain is finely tuned not only to recognize particular sounds, but also to determine which direction they came...

Scientists discover a division of labor between genetic switches

New study on mutation origination fundamentally challenges neo-Darwinism

by Medical Finance
May 19, 2022
0

A new study by a team of researchers from Israel and Ghana has brought the first evidence of nonrandom mutation...

Salk scientists identify a protein that is critical for preventing pancreatic auto-digestion in mice

Salk scientists identify a protein that is critical for preventing pancreatic auto-digestion in mice

by Medical Finance
May 19, 2022
0

Every day, your pancreas produces about one cup of digestive juices, a mixture of molecules that can break down the...

Origins of West African dishes with leafy vegetables date back to 3,500 years

Origins of West African dishes with leafy vegetables date back to 3,500 years

by Medical Finance
May 19, 2022
0

Over 450 prehistoric pots were examined, 66 of them contained traces of lipids, that is, substances insoluble in water. On...

Researchers create a DNA-based fluorescent nanoantenna to monitor the motions of proteins

Researchers use microscopic strands of DNA to assemble hydrogel blocks

by Medical Finance
May 19, 2022
0

Researchers from the Okinawa Institute of Science and Technology Graduate University (OIST) have used microscopic strands of DNA to guide...

Next Post
Nutritional components hold promise for improving the health and well-being of adults

Molecular RNA profile of naked mole-rats reveals new insights on skin aging

Study: Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease. Image Credit: SKK Pix / Shutterstock

Compound found in Datura shows promise as antiviral agent against SARS-CoV-2

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Comparison of neutralizing antibody response following SARS-CoV-2 booster vaccination with breakthrough infection. Image Credit: spaxiax/Shutterstock
    Comparison of neutralizing antibody response following SARS-CoV-2 booster vaccination with breakthrough infection
  • Study: The SARS-CoV2 envelope is distinct from host membranes, exposes pro-coagulant lipids, and can be inactivated in vivo by surfactant-containing oral rinses. Image Credit: goffkein.pro/Shutterstock
    Surfactant-containing oral mouthwashes target the lipid envelope of SARS-CoV-2
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply